September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Mitochondrial Flavoprotein Fluorescence in Glaucoma Suspects, Primary Open-Angle Glaucoma, and Healthy Controls
Author Affiliations & Notes
  • Lawrence Geyman
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Alexander Pinhas
    North Shore-LIJ Health System, Manhasset, New York, United States
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Brian Krawitz
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Shelley Mo
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Matthew Field
    University of Michigan, Ann Arbor, Michigan, United States
  • Richard B Rosen
    New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Lawrence Geyman, None; Alexander Pinhas, None; Brian Krawitz, None; Shelley Mo, None; Matthew Field, OcuSciences (E); Richard Rosen, Advanced Cellular Technologies (C), Allergan (C), Carl Zeiss Meditech (C), Clarity (C), Genetech (F), NanoRetina (C), OD-OS (C), Opticology (I), Optovue (C), Regeneron (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lawrence Geyman, Alexander Pinhas, Brian Krawitz, Shelley Mo, Matthew Field, Richard B Rosen; Mitochondrial Flavoprotein Fluorescence in Glaucoma Suspects, Primary Open-Angle Glaucoma, and Healthy Controls. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Oxidative stress and mitochondrial dysfunction have been linked to the development of glaucoma by several authors. Previously, we reported increased flavoprotein fluorescence (FPF) in patients with moderate to advanced primary open-angle glaucoma (POAG) as compared to age-matched controls. In this study, we measured the level of FPF in eyes classified as glaucoma suspects (GS) and compared them to healthy controls and to patients receiving treatment for POAG.

Methods : 7 GS patients (7 eyes, mean age 56, range 48-68 years), 14 POAG patients (14 eyes, mean age 57, range 44-68 years), and 12 age-matched controls (12 eyes, mean age 52, range 42-65 years) were imaged with the OcuMet Beacon retinal metabolic analyzer (OcuSciences, Ann Arbor, MI). Images were obtained over 13-degree circular fields centered at the macula and optic disc. A histogram curve of pixel intensities for each image was generated. Average FPF intensity was calculated from all pixels within the circular field. FPF heterogeneity was determined from the width of the histogram curve at one-half the maximum FPF frequency (Fig. A). Unpaired Student’s t-tests were used to assess statistical significance.

Results : Average FPF intensity was significantly higher in GS eyes compared to control eyes at both the macula (383±74 vs 290±77, p=0.021) and optic disc (407±58 vs 309±74, p=0.0093). FPF heterogeneity was significantly higher in GS eyes compared to control eyes at the optic disc (197±31 vs 134±31, p<0.001), but not at the macula (159±34 vs 126±44, p=0.10). Average FPF intensity and FPF heterogeneity of POAG eyes at the macula (374±114 and 151±39, respectively) and optic disc (390±110 and 176±44, respectively) were similar to glaucoma suspects (Fig. B).

Conclusions : FPF appears sensitive to underlying mitochondrial dysfunction in GS eyes at both the macula and the optic disc and may prove a useful metric for identifying the earliest evidence of glaucoma. Lack of difference between GS and POAG patients may be due to effects of treatment on the POAG group. Longitudinal studies to correlate clinical variables to changes in FPF will help to define potential roles for the RMA in the detection and management of glaucomatous change.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

Fig. A: FPF heterogeneity indicated by the horizontal solid line.

Fig. A: FPF heterogeneity indicated by the horizontal solid line.

 

Fig. B: Histograms of the average FPF intensity and FPF heterogeneity (error bars indicate standard error of the mean).

Fig. B: Histograms of the average FPF intensity and FPF heterogeneity (error bars indicate standard error of the mean).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×